Dec 9, 2022
Neosoma Participates in Big Data Federated Learning Study
UPenn-led study brought together almost 6,500 brain cancer MRIs from 71 sites on 6 continents to study the benefits of federated-learning-based AI on glioblastoma segmentation.
Sep 29, 2022
Neosoma Announces FDA 510(k) Clearance for Neosoma HGG
Neosoma Announced Today It Has Received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Its First AI-Based Neuro-Oncology Software, Neosoma HGG